合成目标产物 Omecamtiv Mecarbil 主要起始原料 5-Isocyanato-2-Methyl-Pyridine And 4-(3-Amino-2-Fluoro-Benzyl)-Piperazine-1-Carboxylic Acid Methyl Ester
1628206-34-7 + 873697-70-2 = 873697-71-3 反应条件:1.1 Reagents: Diisopropylethylamine Solvents: Acetonitrile,Tetrahydrofuran; 21 H,57 °C 标题:Development Of A Factory Process For Omecamtiv Mecarbil,A Novel Cardiac Myosin Activator 作者:Caille,Seb; Allgeier,Alan M.; Bernard,Charles; Correll,Tiffany L.; Cosbie,Andrew; Et Al 参考文献:Organic Process Research & Development 日期:2019 卷标:23(8) 页码:1558-1567]
732245-99-7 + 873697-70-2 = 873697-71-3 反应条件:1.1 Solvents: Acetone; 4 Min,40 +/- 5 °C; 5 Min,40 °C -> Reflux; 250 Min,Reflux; 460 Min,Reflux -> 30 °C; 5 H,< 30 °C 标题:Discovery Of Omecamtiv Mecarbil The First,Selective,Small Molecule Activator Of Cardiac Myosin 作者:Morgan,Bradley P.; Muci,Alexander; Lu,Pu-Ping; Qian,Xiangping; Tochimoto,Todd; Et Al 参考文献:Acs Medicinal Chemistry Letters 日期:2010 卷标:1(9) 页码:472-477]
917-61-3 + 1309439-45-9 + 3430-14-6 = 873697-71-3 反应条件:1.1 Catalysts: Tris(Dibenzylideneacetone)Dipalladium,[3,6-Dimethoxy-2′,4′,6′-Tris(1-Methylethyl)[1,1′-Biphenyl]-2-Yl]Bis(1,1-Dimethyl... Solvents: Toluene; 3 Min,120 °C1.2 Reagents: Phenol,Triethylamine; Rt -> 120 °C; 16 H,120 °C; 120 °C -> Rt1.3 Solvents: Toluene; 15 H,80 °C 标题:Palladium-Catalyzed Cross-Coupling Of Aryl Chlorides And Triflates With Sodium Cyanate: A Practical Synthesis Of Unsymmetrical Ureas 作者:Vinogradova,Ekaterina V.; Fors,Brett P.; Buchwald,Stephen L. 参考文献:Journal Of The American Chemical Society 日期:2012 卷标:134(27) 页码:11132-11135
专利号:US-11702380-B2 优先权日:2021-03-10 标 题:Synthesis of omecamtiv mecarbil 发明人:CAILLE SEBASTIEN; MURRAY JAMES; QUASDORF KYLE; NGUYEN HANNAH; SILVA ELIPE MARIA VICTORIA; ERICSON ARI ELIZABETH 权利人:AMGEN INC 摘要:Provided herein are synthetic methods for the preparation of intermediates that are utilized in the synthesis of omecamtiv mecarbil dihydrochloride.
专利号:US-12269811-B2 优先权日:2017-06-30 标 题:Synthesis of omecamtiv mecarbil 发明人:CAILLE SEBASTIEN; QUASDORF KYLE; ROOSEN PHILIPP C; SHI XIANQING; COSBIE ANDREW; WANG FANG; WU ZUFAN; NEERGUNDA ARCHANA; QUAN BIN PETER; GUAN LIANXIU 权利人:AMGEN INC 摘要:Provided herein is a synthesis for omecamtiv mecarbil dihydrochloride hydrate and various intermediates. (1)
专利号:US-2023373955-A1 优先权日:2017-06-30 标 题:Synthesis of omecamtiv mecarbil
专利号:US-2022298099-A1 优先权日:2021-03-10 标题:Synthesis of omecamtiv mecarbil
专利号:TW-202300479-A 优先权日:2021-03-10 标 题:Synthesis of omecamtiv mecarbil
专利号:WO-2022192414-A2 优先权日:2021-03-10 标题:Synthesis of omecamtiv mecarbil
1: Teerlink JR, Diaz R, Felker GM, McMurray JJV, Metra M, Solomon SD, Adams KF, Anand I, Arias-Mendoza A, Biering-Sørensen T, Böhm M, Bonderman D, Cleland JGF, Corbalan R, Crespo-Leiro MG, Dahlström U, Echeverria LE, Fang JC, Filippatos G, Fonseca C, Goncalvesova E, Goudev AR, Howlett JG, Lanfear DE, Li J, Lund M, Macdonald P, Mareev V, Momomura SI, O'Meara E, Parkhomenko A, Ponikowski P, Ramires FJA, Serpytis P, Sliwa K, Spinar J, Suter TM, Tomcsanyi J, Vandekerckhove H, Vinereanu D, Voors AA, Yilmaz MB, Zannad F, Sharpsten L, Legg JC, Varin C, Honarpour N, Abbasi SA, Malik FI, Kurtz CE; GALACTIC-HF Investigators. Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure. N Engl J Med. 2021 Jan 14;384(2):105-116. doi: 10.1056/NEJMoa2025797. Epub 2020 Nov 13. 8(4):329-340. doi: 10.1016/j.jchf.2019.12.001. Epub 2020 Feb 6. 15(2):102-113. doi: 10.2174/1573403X15666181212125024. 4: Zhou S, Liu Y, Huang X, Wu C, Pórszász R. Omecamtiv Mecarbil in the treatment of heart failure: the past, the present, and the future. Front Cardiovasc Med. 2024 Mar 19;11:1337154. doi: 10.3389/fcvm.2024.1337154. 5: Nanasi P, Komaromi I, Gaburjakova M, Almassy J. Omecamtiv Mecarbil: A Myosin Motor Activator Agent with Promising Clinical Performance and New in vitro Results. Curr Med Chem. 2018;25(15):1720-1728. doi: 10.2174/0929867325666171222164320. 25(1):117-27. doi: 10.1517/13543784.2016.1123248. Epub 2015 Dec 19. 74(3):155-162. doi: 10.1016/j.ihj.2022.03.005. Epub 2022 Mar 15.
合成参考文献
参考文献:10.1016/j.yjmcc.2011.05.006 摘要:Malik FI, Morgan BP. Cardiac myosin activation part 1: From concept to clinic. Journal of Molecular and Cellular Cardiology. 2011 Oct;51(4):454–61. doi: 10.1016/j.yjmcc.2011.05.006. 参考文献:10.1124/dmd.121.000444 摘要:Trivedi A, Wahlstrom J, Mackowski M, Dutta S, Lee E. Pharmacokinetics, Disposition, and Biotransformation of [14C]Omecamtiv Mecarbil in Healthy Male Subjects after a Single Intravenous or Oral Dose. Drug Metab Dispos. 2021 Aug;49(8):619–28. doi: 10.1124/dmd.121.000444.